Looking Ahead, States Begin Casting Biosimilar Safety Net
While the FDA is still waiting for its first biosimilar application to be submitted, a few states with the encouragement of patient advocacy groups and the biopharma industry are already casting a safety net for when interchangeable biologics hit the U.S. market.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST